Literature DB >> 15614139

Procuring organ donors as a health investment: how much should we be willing to spend?

John Mendeloff1, Kilkon Ko, Mark S Roberts, Margaret Byrne, Mary Amanda Dew.   

Abstract

BACKGROUND: This paper examines the benefits and costs that accrue when a cadaveric organ donor is procured. We estimate the cost per quality-adjusted life year (QALY) for donor procurement. Our objective was not only to see whether organ procurement is a "good" health investment, but also to clarify how much it is worth spending to obtain additional donors.
METHODS: We calculated the average number of kidney, heart, and liver transplants that a typical cadaveric donor generates. Relying primarily on reviewing the published literature, we estimated for each organ type the average number of QALYs that transplants add and the average medical costs they generate. We multiplied per organ benefits and costs by the number of organs from the typical donor, and summed the results to calculate the cost per QALY from procuring an additional donor. We conducted extensive sensitivity analyses of the assumptions.
RESULTS: Our central estimate indicates that the typical donor generates about 13 QALYs at an added medical cost of about $214,000, a cost of approximately $16,000 per QALY. Our high estimate is approximately $57,000.
CONCLUSIONS: The implications of these findings depend upon how we choose to value QALYs. Most analysts agree that a figure of $100,000 is reasonable. At this value, the benefit obtained from one added donor would be $1.3 million (13 x $100,000) while the medical costs would be $214,000. The implication is that we should be willing to spend up to $1,086,000 ($1.3 million - $214,000) to obtain one more donor.

Entities:  

Mesh:

Year:  2004        PMID: 15614139     DOI: 10.1097/01.tp.0000149787.97288.a2

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Measuring the value of public health systems: the disconnect between health economists and public health practitioners.

Authors:  Peter J Neumann; Peter D Jacobson; Jennifer A Palmer
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

Review 2.  A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy.

Authors:  Joseph Menzin; Lisa M Lines; Daniel E Weiner; Peter J Neumann; Christine Nichols; Lauren Rodriguez; Irene Agodoa; Tracy Mayne
Journal:  Pharmacoeconomics       Date:  2011-10       Impact factor: 4.981

3.  Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis.

Authors:  J C Lai; J G Kahn; M Tavakol; M G Peters; J P Roberts
Journal:  Am J Transplant       Date:  2013-08-22       Impact factor: 8.086

4.  Individualized cost-effectiveness analysis.

Authors:  John P A Ioannidis; Alan M Garber
Journal:  PLoS Med       Date:  2011-07-12       Impact factor: 11.069

5.  Multi-state survival analysis in renal transplantation recipients.

Authors:  Moghaddameh Mirzaee; Kazem Mohammad; Mahmood Mahmoodi; Hojjat Zeraati; Mohammad-Reza Ebadzadeh; Abbas Etminan; Faramarz Fazeli; Mohammad Hasan Dehghani Firouzabadi; Hossein Sattary; Mahdiyeh Haghparast; Abbas Rahimi Foroushani
Journal:  Iran J Public Health       Date:  2014-03       Impact factor: 1.429

6.  Patient Survival in Renal Allograft Failure: A Time-dependent Analysis.

Authors:  Moghaddameh Mirzaee; Jalal Azmandian; Hojjat Zeraati; Mahmood Mahmoodi; Kazem Mohammad; Faramarz Fazeli; Mohammad-Reza Ebadzadeh
Journal:  Nephrourol Mon       Date:  2013-10-30

7.  Can education alter attitudes, behaviour and knowledge about organ donation? A pretest-post-test study.

Authors:  Donal McGlade; Barbara Pierscionek
Journal:  BMJ Open       Date:  2013-12-30       Impact factor: 2.692

8.  Mixed method versus full top-down microcosting for organ recovery cost assessment in a French hospital group.

Authors:  Abdelbaste Hrifach; Coralie Brault; Sandrine Couray-Targe; Lionel Badet; Pascale Guerre; Christell Ganne; Hassan Serrier; Vanessa Labeye; Pierre Farge; Cyrille Colin
Journal:  Health Econ Rev       Date:  2016-11-28

Review 9.  Intimacy or utility? Organ donation and the choice between palliation and ventilation.

Authors:  Aric Bendorf; Ian H Kerridge; Cameron Stewart
Journal:  Crit Care       Date:  2013-05-23       Impact factor: 9.097

10.  Cadaver transplantation in Recent Era: Is Cadaveric Graft Survival Similar to Living Kidney Transplantation?

Authors:  N Simforoosh; S Gooran; A Tabibi; A Bassiri; M R Ghraati
Journal:  Int J Organ Transplant Med       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.